The DOI matches its Crossref record; 38 of the 40 references it cites were found in a registry or an index.
Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease
Open accessAbstract
We conducted a meta-analysis of Parkinson's disease genome-wide association studies using a common set of 7,893,274 variants across 13,708 cases and 95,282 controls. Twenty-six loci were identified as having genome-wide significant association; these and 6 additional previously reported loci were then tested in an independent set of 5,353 cases and 5,551 controls. Of the 32 tested SNPs, 24 replicated, including 6 newly identified loci. Conditional analyses within loci showed that four loci, including GBA, GAK-DGKQ, SNCA and the HLA region, contain a secondary independent risk variant. In total, we identified and replicated 28 independent risk variants for Parkinson's disease across 24 loci. Although the effect of each individual locus was small, risk profile analysis showed substantial cumulative risk in a comparison of the highest and lowest quintiles of genetic risk (odds ratio (OR) = 3.31, 95% confidence interval (CI) = 2.55-4.30; P = 2 × 10(-16)). We also show six risk loci associated with proximal gene expression or DNA methylation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Subsequently, rare families with biallelic loss of function mutations in GRN were identified, and affected individuals were found to have a juvenile-onset neuronal ceroid lipofuscinosis (NCL).114–116”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [114]
Experimental — accuracy not yet measuredIn the citing paper
“While only <10% of the heritability of PD has been explained by current genetic findings (Darweesh et al., 2016; Nalls et al., 2014; Pihlstrom et al., 2016), and while the clinical utility of genetic testing for PD outside of early onset patient populations is limited (Klein & Westenberger, 2012), genetic risk models have been shown to predict PD status from healthy controls, or correlate with”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Nalls et al., 2014
In the citing paper
“First, a relatively small proportion (<10%) of the heritability of PD has been explained by current GWAS findings (Darweesh et al., 2016; Nalls et al., 2014; Pihlstrom et al., 2016)”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Nalls et al., 2014
In the citing paper
“A PD polygenic risk score was calculated using a weighted allele-counting approach (Dudbridge, 2013) based on known, common PD susceptibility loci, derived from the largest and most recent PD genome-wide association study (GWAS) meta-analysis (Nalls et al., 2014).”
From Combined accelerometer and genetic analysis to differentiate essential tremor from Parkinson’s disease (2018) · cites this paper as Nalls et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877
METAL: fast and efficient meta-analysis of genomewide association scans
Willer, C. J., Li, Y., & Abecasis, G. R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq340 · Cited by 5,205
Fast and accurate genotype imputation in genome-wide association studies through pre-phasing
Howie, B., Fuchsberger, C., Stephens, M., Marchini, J., & Abecasis, G. R. (2012) · Nature Genetics · doi:10.1038/ng.2354 · Cited by 1,737
The Rotterdam Study: objectives and design update
Albert Hofman, D., Breteler, M. M. B., van Duijn, C. M., Krestin, G. P., Pols, H. A. P., Stricker, B. H. C., Tiemeier, H. W., Uitterlinden, A. G., Vingerling, J. R., & Witteman, J. C. M. (2007) · European Journal of Epidemiology · doi:10.1007/s10654-007-9199-x · Cited by 1,408
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,338
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132
Nalls, M. A. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62345-8 · Cited by 922
Self-citationHamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 808
Self-citationAbundant quantitative trait loci exist for DNA methylation and gene expression in human brain
Gibbs, J. R., van der Brug, M. P., Hernandez, D. G., Traynor, B. J., Nalls, M. A., Lai, S.-L., Arepalli, S., Dillman, A., Rafferty, I. P., Troncoso, J., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1000952 · Cited by 769
Self-citationHan, B., & Eskin, E. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.04.014 · Cited by 680
Flagged first, then by citations
2 of the 40 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 601–700 of 1,004
Discovering the 3′ UTR-mediated regulation of alpha-synuclein
Marchese, D., Botta-Orfila, T., Cirillo, D., Rodriguez, J. A., Livi, C. M., Fernández-Santiago, R., Ezquerra, M., Martí, M. J., Bechara, E., Tartaglia, G. G., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1048 · Cited by 45
The aging immune system in Alzheimer’s and Parkinson’s diseases
Heavener, K. S., & Bradshaw, E. M. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00944-6 · Cited by 51
Transcriptomic profiles in Parkinson’s disease
Kurvits, L., Lättekivi, F., Reimann, E., Kadastik‐Eerme, L., Kasterpalu, K. M., Kõks, S., Taba, P., & Planken, A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370220967325 · Cited by 46
Abrishamdar, M., Jalali, M. S., & Rashno, M. M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02899-z · Cited by 45
LRRK2 variation and dementia with Lewy bodies
Heckman, M. G., Soto‐Ortolaza, A. I., Sánchez-Contreras, M., Murray, M. E., Pedraza, O., Diehl, N. N., Walton, R. L., Labbé, C., Lorenzo‐Betancor, O., Uitti, R. J., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.07.015 · Cited by 46
Haplotype phasing of whole human genomes using bead-based barcode partitioning in a single tube
Zhang, F., Christiansen, L., Thomas, J., Pokholok, D., Jackson, R., Morrell, N., Zhao, Y., Wiley, M., Welch, E., Jaeger, E. B., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3897 · Cited by 46
Yu, H., You, X., Li, J., Zhang, X., Zhang, S., Jiang, S., Lin, X., Lin, H., Meng, Z., & Shi, Q. (2018) · Science China Life Sciences · doi:10.1007/s11427-017-9161-4 · Cited by 46
The Physiology of Homeoprotein Transduction
Nardo, A. A. D., Fuchs, J., Joshi, R. L., Moya, K. L., & Prochiantz, A. (2018) · Physiological Reviews · doi:10.1152/physrev.00018.2017 · Cited by 52
Genetic Risk Underlying Psychiatric and Cognitive Symptoms in Huntington’s Disease
Ellis, N., Tee, A., McAllister, B., Massey, T. H., McLauchlan, D. J., Stone, T., Correia, K., Loupe, J. M., Kim, K., Barker, D., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.12.010 · Cited by 48
Self-citationVohra, M., Sharma, A. R., Prabhu, N. B., & Padmalatha, S. (2020) · Public Health Genomics · doi:10.1159/000510253 · Cited by 49
Molecular events underlying the cell‐to‐cell transmission of α‐synuclein
Choi, Y. R., Park, S., & Park, S. M. (2020) · FEBS Journal · doi:10.1111/febs.15674 · Cited by 47
Predictors of RBD progression and conversion to synucleinopathies
de Natale, E. R., Wilson, H., & Politis, M. (2022) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-022-01171-0 · Cited by 49
Yang, R., Xue, H., Yu, L., Velayos‐Baeza, A., Monaco, A. P., & Liu, F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153534 · Cited by 46
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies
Labbé, C., Heckman, M. G., Lorenzo‐Betancor, O., Soto‐Ortolaza, A. I., Walton, R. L., Murray, M. E., Allen, M., Uitti, R. J., Wszołek, Z. K., Smith, G. E., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.05.002 · Cited by 49
Epidemiologie und Ursachen der Parkinson-Erkrankung
Lill, C. M., & Klein, C. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0288-0 · Cited by 47
Self-citationG2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain
Nguyen, A. P. T., Daniel, G., Valdés, P., Islam, M. S., Schneider, B. L., & Moore, D. J. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx389 · Cited by 46
Sleep disorders and Parkinson disease; lessons from genetics
Gan‐Or, Z., Alcalay, R. N., Rouleau, G. A., & Postuma, R. B. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.01.006 · Cited by 47
Deconstructing and targeting the genomic architecture of human neurodegeneration
Jager, P. L. D., Yang, H., & Bennett, D. A. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0240-z · Cited by 46
Heritability and genetic variance of dementia with Lewy bodies
Guerreiro, R. J., Escott‐Price, V., Hernandez, D. G., Kun‐Rodrigues, C., Ross, O. A., Orme, T., Neto, J. L., Carmona, S., Dehghani, N., Eicher, J. D., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.04.004 · Cited by 48
Self-citationRisky behaviors and Parkinson disease
Grover, S., Del, G. M. F., Kasten, M., Klein, C., Lill, C. M., & König, I. R. (2019) · Neurology · doi:10.1212/wnl.0000000000008245 · Cited by 48
Self-citationAPOE and MAPT Are Associated With Dementia in Neuropathologically Confirmed Parkinson's Disease
Tunold, J., Geut, H., Rozemüller, A. J. M., Henriksen, S. P., Toft, M., van de Berg, W. D. J., & Pihlstrøm, L. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.631145 · Cited by 49
Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
Zou, L., Tian, Y., & Zhang, Z. (2021) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2021.619160 · Cited by 44
Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders
Marchi, F. D., Munitić, I., Vidatic, L., Papić, E., Rački, V., Nimac, J., Jurak, I., Novotni, G., Rogelj, B., Vuletić, V., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102793 · Cited by 47
Genome-wide assessment of Parkinson's disease in a Southern Spanish population
Bandrés‐Ciga, S., Price, T. R., Barrero, F. J., Sevilla, F. E., Pelegrina, J., Arepalli, S., Hernandez, D. G., Gutiérrez, B., Cervilla, J. A., Rivera, M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.06.001 · Cited by 45
Self-citationLopes, F. M., Bristot, I. J., da Motta, L. L., Parsons, R. B., & Klamt, F. (2017) · NeuroMolecular Medicine · doi:10.1007/s12017-017-8454-x · Cited by 48
Íñigo-Marco, I., Valencia, M., Larrea, L., Bugallo, R., Martínez-Goikoetxea, M., Zuriguel, I., & Arrasate, M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703420114 · Cited by 44
Cognitive and Neuropsychiatric Features of Early Parkinson's Disease
Getz, S. J., & Levin, B. E. (2017) · Archives of Clinical Neuropsychology · doi:10.1093/arclin/acx091 · Cited by 47
Tomkins, J. E., Dihanich, S., Beilina, A. G., Ferrari, R., Ilacqua, N., Cookson, M., Lewis, P. A., & Manzoni, C. (2018) · PROTEOMICS · doi:10.1002/pmic.201700444 · Cited by 44
Uenaka, T., Satake, W., Cha, P.-C., Hayakawa, H., Baba, K., Jiang, S., Kobayashi, K., Kanagawa, M., Okada, Y., Mochizuki, H., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy279 · Cited by 45
Elvsåshagen, T., Bahrami, S., van der Meer, D., Agartz, I., Alnæs, D., Barch, D. M., Baur‐Streubel, R., Bertolino, A., Beyer, M. K., Blasi, G., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17376-1 · Cited by 47
Epigenetic Modulation in Parkinson’s Disease and Potential Treatment Therapies
Rathore, A. S., Birla, H., Singh, S. S., Zahra, W., Dilnashin, H., Singh, R., Keshri, P. K., & Singh, S. P. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03334-w · Cited by 45
Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury
Boddu, R., Hull, T. D., Bolisetty, S., Hu, X., Moehle, M. S., Daher, J. P. L., Kamal, A., Joseph, R., George, J. F., Agarwal, A., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv147 · Cited by 43
Network and Pathway-Based Analyses of Genes Associated with Parkinson’s Disease
Hu, Y., Pan, Z., Hu, Y. C., Zhang, L., & Wang, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9998-8 · Cited by 43
Ishikawa, T., Imamura, K., Kondo, T., Koshiba, Y., Hara, S., Ichinose, H., Furujo, M., Kinoshita, M., Oeda, T., Takahashi, J., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw339 · Cited by 44
Nakhaei‐Rad, S., Haghighi, F., Nouri, P., Adariani, S. R., Lissy, J., Jasemi, N. S. K., Dvorský, R., & Ahmadian, M. R. (2018) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2018.1431605 · Cited by 44
Polygenic Risk Scores in Neurodegenerative Diseases: a Review
Ibáñez, L., Farias, F., Dube, U., Mihindukulasuriya, K. A., & Harari, O. (2019) · Current Genetic Medicine Reports · doi:10.1007/s40142-019-0158-0 · Cited by 42
Lavenir, I., Passarella, D., Masuda‐Suzukake, M., Curry, A., Holton, J. L., Ghetti, B. F., & Goedert, M. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0804-5 · Cited by 43
Whole-exome sequencing in early-onset Parkinson's disease among ethnic Chinese
Li, N., Wang, L., Zhang, J., Tan, E., Li, J., Peng, J., Duan, L., Chen, C., Zhou, D., He, L., et al. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.12.023 · Cited by 44
Vinueza‐Gavilanes, R., Íñigo-Marco, I., Larrea, L., Lasa, M., Carte, B., Santamaría, E., Fernández‐Irigoyen, J., Bugallo, R., Aragón, T., Aldabe, R., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104781 · Cited by 44
Absence of Sac2/INPP5F enhances the phenotype of a Parkinson’s disease mutation of synaptojanin 1
Cao, M., Park, D., Wu, Y.-M., & Camilli, P. D. (2020) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.2004335117 · Cited by 43
Smolders, S., Philtjens, S., Crosiers, D., Sieben, A., Hens, E., Heeman, B., Mossevelde, S. V., Pals, P., Asselbergh, B., Dias, R. A., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01121-w · Cited by 45
iPSC-Derived Microglia as a Model to Study Inflammation in Idiopathic Parkinson’s Disease
Badanjak, K., Mulica, P., Smajić, S., Delcambre, S., Tranchevent, L.-C., Diederich, N. J., Rauen, T., Schwamborn, J. C., Glaab, E., Cowley, S. A., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740758 · Cited by 45
NEAT1 on the Field of Parkinson’s Disease: Offense, Defense, or a Player on the Bench?
Boros, F. A., Vécsei, L., & Klivènyi, P. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202374 · Cited by 42
Multi-omic insights into Parkinson's Disease: From genetic associations to functional mechanisms
Schilder, B. M., Navarro, E., & Raj, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105580 · Cited by 45
Unraveling the complex role of MAPT-containing H1 and H2 haplotypes in neurodegenerative diseases
Pedicone, C., Weitzman, S. A., Renton, A. E., & Goate, A. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00731-x · Cited by 42
Self-citationZhang, J., Zhang, X., Wang, L., & Yang, C. (2017) · Medical Science Monitor · doi:10.12659/msm.904399 · Cited by 42
6‐n‐propylthiouracil taste disruption and TAS2R38 nontasting form in Parkinson's disease
Cossu, G., Melis, M., Sarchioto, M., Melis, M., Melis, M., Morelli, M., & Barbarossa, I. T. (2018) · Movement Disorders · doi:10.1002/mds.27391 · Cited by 42
Genetically engineered animal models of Parkinson's disease: From worm to rodent
Breger, L. S., & Armentero, M. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.14300 · Cited by 45
Tao, F., Beecham, G. W., Rebelo, A. P., Svaren, J. P., Blanton, S. H., Moran, J. J. M., Lopez‐Anido, C., Morrow, J. M., Abreu, L., Rizzo, D. N., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25426 · Cited by 42
Prasuhn, J., Brüggemann, N., Heßler, N., Berg, D., Gasser, T., Brockmann, K., Olbrich, D., Ziegler, A., König, I. R., Klein, C., et al. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0033-1 · Cited by 42
Self-citationOmics in Neurodegenerative Disease: Hope or Hype?
Diaz‐Ortiz, M. E., & Chen‐Plotkin, A. S. (2020) · Trends in Genetics · doi:10.1016/j.tig.2019.12.002 · Cited by 41
Blood Exosomes Have Neuroprotective Effects in a Mouse Model of Parkinson’s Disease
Sun, T., Ding, Z.-X., Luo, X., Liu, Q., & Cheng, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3807476 · Cited by 42
Uncovering the impact of noncoding variants in neurodegenerative brain diseases
Frydas, A., Wauters, E., van der Zee, J., & Broeckhoven, C. V. (2021) · Trends in Genetics · doi:10.1016/j.tig.2021.08.010 · Cited by 44
LRRK2 mutant knock-in mouse models: therapeutic relevance in Parkinson's disease
Chang, E. E. S., Ho, P. W., Liu, H., Pang, S. Y.-Y., Leung, C.-T., Malki, Y., Choi, Z. Y.-K., Ramsden, D. B., & Ho, S. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00285-2 · Cited by 45
Török, N., Maszlag-Török, R., Molnár, K., Szolnoki, Z., Somogyvári, F., Boda, K., Tanaka, M., Klivènyi, P., & Vécsei, L. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2709265 · Cited by 42
Exploring Human-Genome Gut-Microbiome Interaction in Parkinson’s Disease
Wallen, Z. D., Stone, W. J., Factor, S. A., Molho, E., Zabetian, C. P., Standaert, D. G., & Payami, H. (2021) · npj Parkinson s Disease · doi:10.1038/s41531-021-00218-2 · Cited by 41
Self-citationPostsynaptic synucleins mediate endocannabinoid signaling
Albarran, E., Sun, Y., Liu, Y., Raju, K., Dong, A., Li, Y., Wang, S., Südhof, T. C., & Ding, J. (2023) · Nature Neuroscience · doi:10.1038/s41593-023-01345-0 · Cited by 40
Expanding causal genes for Parkinson’s disease via multi-omics analysis
Gu, X., Su, W., Dou, M., Jiang, Z., Duan, Q., Yin, K., Cao, B., Wang, Y., Li, G., & Chen, Y. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00591-0 · Cited by 43
Kang, H., & Lee, C. J. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01206-1 · Cited by 40
Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease
Lewthwaite, A. J., Lambert, T. D., Rolfe, E. B., Olgiati, S., Quadri, M., Simons, E. J., Morrison, K. E., Bonifati, V., & Nicholl, D. J. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.01.004 · Cited by 41
Biernacka, J. M., Chung, S. J., Armasu, S. M., Anderson, K. S., Lill, C. M., Bertram, L., Ahlskog, J. E., Brighina, L., Frigerio, R., & Maraganore, D. M. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.002 · Cited by 40
Self-citationGuebel, D. V., & Torres, N. V. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00229 · Cited by 41
Neuroinflammation — using big data to inform clinical practice
Dendrou, C. A., McVean, G., & Fugger, L. H. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.171 · Cited by 43
Milestones of Parkinson’s Disease Research: 200 Years of History and Beyond
Li, S., & Le, W. (2017) · Neuroscience Bulletin · doi:10.1007/s12264-017-0178-2 · Cited by 49
AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression
Cho, H. J., Xie, C., & Cai, H. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0106-z · Cited by 41
The impact of indigenous microbes on Parkinson's disease
Sampson, T. R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.03.014 · Cited by 41
Schaffner, S. L., & Kobor, M. S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.971298 · Cited by 42
Gerraty, R. T., Provost, A. C., Li, L., Wagner, E. A., Haas, M., & Lancashire, L. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1076657 · Cited by 43
Merchant, K., Simuni, T., Fedler, J. K., Caspell‐Garcia, C., Brumm, M. C., Nudelman, K. N. H., Tengstrandt, E., Hsieh, F., Alcalay, R. N., Coffey, C. S., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00468-2 · Cited by 40
Self-citationThe cervical lymph node contributes to peripheral inflammation related to Parkinson’s disease
Liu, Z., Huang, Y., Wang, X.-J., Li, J.-Y., Zhang, C., Yang, Y., & Zhang, J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02770-5 · Cited by 33
Firdaus, Z., & Li, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042320 · Cited by 46
Todorovic, M., Newman, J. R. B., Shan, J., Bentley, S. R., Wood, S. A., Silburn, P. A., & Mellick, G. D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128030 · Cited by 40
Genetics of movement disorders in the next‐generation sequencing era
Olgiati, S., Quadri, M., & Bonifati, V. (2016) · Movement Disorders · doi:10.1002/mds.26521 · Cited by 43
Overlapping genetic architecture between Parkinson disease and melanoma
Dube, U., Ibáñez, L., Budde, J., Benítez, B. A., Davis, A. A., Harari, O., Iles, M. M., Law, M. H., Brown, K. M., & Cruchaga, C. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02110-z · Cited by 40
Rodrigues, P. V., de Godoy, J. V. P., Bosque, B. P., Neto, D. P. A., Tostes, K., Palameta, S., Garcia-Rosa, S., Tonoli, C. C. C., Carvalho, H. F., & Fonseca, M. D. C. (2022) · Scientific Reports · doi:10.1038/s41598-022-08076-5 · Cited by 40
Dysregulation of peripheral monocytes and pro-inflammation of alpha-synuclein in Parkinson’s disease
Su, Y., Shi, C., Wang, T., Liu, C., Yang, J., Zhang, S., Fan, L., Zheng, H., Li, X., Luo, H., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11258-w · Cited by 38
Leyns, C. E. G., Prigent, A., Beezhold, B., Yao, L., Hatcher, N. G., Tao, P., Kang, J. J., Suh, E. R., Deerlin, V. M. V., Trojanowski, J. Q., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00517-w · Cited by 38
Zou, Y., Stagi, M., Wang, X., Yiğitkanlı, K., Siegel, C., Nakatsu, F., Cafferty, W. B. J., & Strittmatter, S. M. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.1718-15.2015 · Cited by 38
Host genetic studies in adult pulmonary tuberculosis
Meyer, C. G., & Thye, T. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.09.005 · Cited by 39
Liu, G., Bao, X., Jiang, Y., Liao, M., Jiang, Q., Feng, R., Zhang, L., Ma, G., Chen, Z., Wang, G., et al. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8946-8 · Cited by 42
Stegemann, S. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2015.11.003 · Cited by 39
Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype
Cooper, C. A., Jain, N., Gallagher, M. D., Weintraub, D. A., Xie, S. X., Berlyand, Y., Espay, A. J., Quinn, J. F., Edwards, K. L., Montine, T. J., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.371 · Cited by 39
Wangler, M. F., Hu, Y., & Shulman, J. M. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.027680 · Cited by 41
Mechanisms of Mutant LRRK2 Neurodegeneration
Cookson, M. R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-49969-7_12 · Cited by 41
Glucocerebrosidase haploinsufficiency in A53T α-synuclein mice impacts disease onset and course
Tayebi, N., Parisiadou, L., Berhe, B. A., Gonzalez, A. N., Serra‐Vinardell, J., Tamargo, R., Maniwang, E., Sorrentino, Z. A., Fujiwara, H., Grey, R. J., et al. (2017) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2017.11.001 · Cited by 39
Ferrari, R., Kia, D. A., Tomkins, J. E., Hardy, J., Wood, N. W., Lovering, R. C., Lewis, P. A., & Manzoni, C. (2018) · BMC Genomics · doi:10.1186/s12864-018-4804-9 · Cited by 39
Self-citationCommon and rare GCH1 variants are associated with Parkinson's disease
Rudakou, U., Bencheikh, B. O. A., Ruskey, J. A., Krohn, L., Laurent, S. B., Spiegelman, D., Liong, C., Fahn, S., Waters, C., Monchi, O., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.09.008 · Cited by 39
Biological bases for a possible effect of cannabidiol in Parkinson’s disease
Ferreira‐Junior, N. C., Campos, A. C., Guimarães, F. S., Bel, E. A. D., Zimmermann, P. M. D. R., Brum, L., Hallak, J. E. C., Crippa, J. A. S., & Zuardi, A. W. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0460 · Cited by 44
Long Non-coding RNAs in Parkinson’s Disease
Xin, C., & Liu, J. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03230-3 · Cited by 39
Genome‐Wide Analysis of Structural Variants in Parkinson Disease
Billingsley, K. J., Ding, J., Jerez, P. Á., Illarionova, A., Levine, K. S., Grenn, F. P., Makarious, M. B., Moore, A. K., Vitale, D., Reed, X., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26608 · Cited by 41
Self-citationHunn, B. H. M., Vingill, S., Threlfell, S., Alegre-Abarrategui, J., Magdelyns, M., Deltheil, T., Bengoa-Vergniory, N., Oliver, P. L., Cioroch, M., Doig, N. M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.029 · Cited by 38
Fox, S. N., McMeekin, L. J., Savage, C. H., Joyce, K. L., Boas, S. M., Simmons, M. S., Farmer, C. B., Ryan, J., Pereboeva, L., Becker, K., et al. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00369-w · Cited by 36
Ho, G. P. H., Wilkie, E. C., White, A. J., & Selkoe, D. J. (2023) · Science Signaling · doi:10.1126/scisignal.add7220 · Cited by 40
Infante, J., Prieto, C. A. V., Sierra, M., Sánchez‐Juan, P., Aramburu, I. G., Sánchez‐Quintana, C., Berciano, J., Combarros, O., & Sainz, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.10.026 · Cited by 40
Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies
Labbé, C., Ogaki, K., Lorenzo‐Betancor, O., Soto‐Ortolaza, A. I., Walton, R. L., Rayaprolu, S., Fujioka, S., Murray, M. E., Heckman, M. G., Puschmann, A., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001946 · Cited by 38
Zanforlin, E., Zagotto, G., & Ribaudo, G. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00283 · Cited by 38
Lee, P., Ahmed, I., Loriot, M., Mulot, C., Paul, K. C., Bronstein, J. M., Ritz, B. R., & Elbaz, A. (2018) · Neurology · doi:10.1212/wnl.0000000000004953 · Cited by 38
Genetic Modifiers of Neurodegeneration in a Drosophila Model of Parkinson’s Disease
Lavoy, S., Chittoor-Vinod, V. G., Chow, C. Y., & Martin, I. (2018) · Genetics · doi:10.1534/genetics.118.301119 · Cited by 38
Chaperone-mediated autophagy as a therapeutic target for Parkinson disease
Campbell, P., Morris, H. R., & Schapira, A. H. V. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1517156 · Cited by 39
Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature
Ligaard, J., Sannæs, J., & Pihlstrøm, L. (2019) · npj Parkinson s Disease · doi:10.1038/s41531-019-0091-7 · Cited by 40
Metadata
- Authors
- International Parkinson's Disease Genomics Consortium (IPDGC), Nalls, M. A., Parkinson's Study Group (PSG) Parkinson's Research: The Organized GENetics Initiative (PROGENI), 23andMe, GenePD, NeuroGenetics Research Consortium (NGRC), Hussman Institute of Human Genomics (HIHG), Investigator, T. A. J. D., (CHARGE), C. F. H. A. A. R. I. G. E., North American Brain Expression Consortium (NABEC), United Kingdom Brain Expression Consortium (UKBEC), Greek Parkinson's Disease Consortium, Alzheimer Genetic Analysis Group, Pankratz, N., Lill, C. M., Do, C. B., Hernandez, D. G., Saad, M., DeStefano, A. L., Kara, E., Bras, J., Sharma, M., Schulte, C., Keller, M. F., Arepalli, S., Letson, C., Edsall, C., Stefansson, H., Liu, X., Pliner, H., Lee, J. H., Cheng, R., Ikram, M. A., Ioannidis, J. P. A., Hadjigeorgiou, G. M., Bis, J. C., Martinez, M., Perlmutter, J. S., Goate, A., Marder, K., Fiske, B., Sutherland, M., Xiromerisiou, G., Myers, R. H., Clark, L. N., Stefansson, K., Hardy, J. A., Heutink, P., Chen, H., Wood, N. W., Houlden, H., Payami, H., Brice, A., Scott, W. K., Gasser, T., Bertram, L., Eriksson, N., Foroud, T., & Singleton, A. B.
- Affiliations
- National Institutes of Health (US)
- University of Minnesota (US)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- 23andMe (United States) (US)
- National Hospital for Neurology and Neurosurgery (GB)
- Boston University (US)
- National Institute on Aging (US)
- Université Toulouse III - Paul Sabatier (FR)
- Columbia University Irving Medical Center (US)
- University of Thessaly (GR)
- University of Washington (US)
- Washington University in St. Louis (US)
- deCODE Genetics (Iceland) (IS)
- New York State Department of Health (US)
- University of Miami (US)
- Hertie Institute for Clinical Brain Research (DE)
- Centre National de la Recherche Scientifique (FR)
- Max Planck Institute for Molecular Genetics (DE)
- Indiana University Indianapolis (US)
- Corresponding author
- Singleton, Andrew B
- ORCID
- Nalls, Mike A
- Pankratz, Nathan
- Lill, Christina M
- Hernandez, Dena G
- Saad, Mohamad
- DeStefano, Anita L
- Kara, Eleanna
- Sharma, Manu
- Schulte, Claudia
- Keller, Margaux F
- Letson, Christopher
- Edsall, Connor
- Liu, Xinmin
- Pliner, Hannah
- Lee, Joseph H
- Cheng, Rong
- Ikram, M Arfan
- Ioannidis, John P A
- Bis, Joshua C
- Martinez, Maria
- Perlmutter, Joel S
- Goate, Alison
- Marder, Karen
- Fiske, Brian
- Sutherland, Margaret
- Xiromerisiou, Georgia
- Myers, Richard H
- Clark, Lorraine N
- Hardy, John A
- Heutink, Peter
- Chen, Honglei
- Wood, Nicholas W
- Houlden, Henry
- Payami, Haydeh
- Brice, Alexis
- Scott, William K
- Gasser, Thomas
- Bertram, Lars
- Foroud, Tatiana
- Singleton, Andrew B
- Venue
- Nature Genetics
- Published
- 2014-09
- Volume
- 46
- Issue
- 9
- Pages
- 989-993
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC4146673
- OpenAlex
- W2141459724
- Cited by
- 1,895
- References
- 40
- Citations by year
- 2026: 67 · 2025: 86 · 2024: 103 · 2023: 142 · 2022: 182 · 2021: 194 · 2020: 187 · 2019: 176 · 2018: 212 · 2017: 194 · 2016: 185 · 2015: 140 · 2014: 25
- FWCI
- 24.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- PubMed Central (acceptedVersion)
- Open Research Exeter (University of Exeter) (acceptedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- DZNE Pub (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Radboud Repository (Radboud University) (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion)
- Purdue University Indianapolis (Indiana University) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Hirsla (Landspítali University Hospital) (submittedVersion)
- Funders
- Wellcome Trust (085475, 083948/Z/07/Z, 090355, 089698, 076113, WT089698/Z/09/Z)
- National Institute for Health and Care Research (ACF-2012-17-017)
- Parkinson's UK (F-1202, G-0907, G0909, J‐0804)
- National Institutes of Health (1r01hl120393-01a1, UL1TR001108, UL1TR000124, 5r44hg006981-03, Z01-AG000949)
- Medical Research Council (MC_G1000735, MR/J004758/1, MC_PC_09003, MR/L501554/1, MR/L010305/1, MR/L016400/1, MC_G0901330)
- National Institute on Aging (Z01AG000932, AG-16495, R01AG031287, AG031287, P30AG024826, AG08122, AG033193, AG025259, AG023629, R01AG041797, R01AG016495, P30AG013846, R01AG025259, R01AG033193, R01AG008122, U24AG056270, U24AG021886)
- National Heart, Lung, and Blood Institute (R01-HL120393)
- National Human Genome Research Institute (R44-HG006981)
- National Cancer Institute (R01CA141668)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, P30DK063491)
- National Institute of Neurological Disorders and Stroke (R01NS037167, R21NS050487, NS036630, R01NS036960, NS050487, K23NS070867, R01 NS 36960, NS17950, U01NS082151, R01NS088538, P50NS038377, R01NS076843, R01NS075321, R01NS060113, P50NS071674, K02NS073836, R01NS017950, NS060113)
- National Center for Research Resources (UL1RR024156, KL2RR024154)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, genetic susceptibility loci, genome-wide association study, risk alleles, glucocerebrosidase, SNCA, HLA region, conditional analysis, cumulative genetic risk, gene expression, DNA methylation, replication
- MeSH terms
- Genotype, Humans, Parkinson Disease, Risk Factors, Case-Control Studies, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Genetic Loci
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
